drugset
drugset / Trial / NCT06254976

Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis

NCT06254976 ↗

Completed 30 enrolled Kayseri City Hospital
Non-randomizedSequentialSingle-blindTreatment

Summary

In this study, our objective was to assess the correlation between serum human cartilage glycoprotein-39 (YKL-40) and nesfatin-1 values, the patient's clinical condition, ultrasonographic cartilage thickness measurements, and the response to PRP treatment in knee osteoarthritis (OA)

Timeline

Start
2022-06-01
Primary completion
2023-06-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Platelet Rich Plasma Other / unclassified 3 ml Other

Indications

osteoarthritis, knee